Khasraw, M., West, L., Duan, W., Mukaro, V., Harvey, S., Spokes, R., … Patil, S. (2014). Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer. In Journal of Clinical Oncology (Vol. 32, pp. TPS1135–TPS1135). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.tps1135

Khasraw, Mustafa, Linda West, Wei Duan, Violet Mukaro, Sandra Harvey, Robert Spokes, Conrad Brandt, et al. “Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer.” In Journal of Clinical Oncology, 32:TPS1135–TPS1135. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.tps1135.

Khasraw M, West L, Duan W, Mukaro V, Harvey S, Spokes R, et al. Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. TPS1135–TPS1135.

Khasraw, Mustafa, et al. “Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. TPS1135–TPS1135. Crossref, doi:10.1200/jco.2014.32.15_suppl.tps1135.

Khasraw M, West L, Duan W, Mukaro V, Harvey S, Spokes R, Brandt C, Mitchell G, Prince K, Hayes TM, Baron-Hay SE, Woollett AM, Olesen IH, White K, Bowles S, Wong SF, Ashley DM, Patil S. Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. TPS1135–TPS1135.